Analyses of SARS-CoV-2 microevolution in immunocompromised patients confirmed recurrent deletions in the N-terminal domain of the S glycoprotein that are likely to alter defined antibody epitopes during long-term infections of these patients [11]. The gene discussed is ART4; the disease is infection.